AstraZeneca’s Trixeo Aerosphere has been recommended for approval in the [...]
Tozorakimab has met its primary endpoint in two replicate Phase [...]
AstraZeneca’s Trixeo Aerosphere has been recommended for approval in the [...]
Tozorakimab has met its primary endpoint in two replicate Phase [...]